Trump Claims Credit for 3.1% Drug Price Drop as Experts Tie It to Biden's 2022 Law
Updated
Updated · The Guardian · Aug 15
Trump Claims Credit for 3.1% Drug Price Drop as Experts Tie It to Biden's 2022 Law
3 articles · Updated · The Guardian · Aug 15
Summary
A 3.1% July drop in prescription drug prices — the sharpest in more than 60 years, according to a Washington Post report — was showcased by Trump in a staged photo-op and then amplified across White House social media.
The article Trump highlighted said independent experts instead credit Biden’s 2022 Inflation Reduction Act, which required Medicare to negotiate prices for some costly drugs and began delivering its first cuts this year.
Richard Frank of Harvard and Stacie Dusetzina of Vanderbilt told the Post the negotiated prices for 10 widely used drugs are the likeliest driver of the decline, not Trump administration actions.
White House accounts posted the headline without that context, with press secretary Karoline Leavitt and communications director Steven Cheung echoing Trump’s claim that the drop was “all thanks” to him.